
Analysts Viewpoint
AARD (Aardvark Therapeutics Inc) may reap gains as insiders became active recently
Aardvark Therapeutics Inc’s recent filing unveils that its Director VICKERS VENT GLB DEEP-TECH FND acquired Company’s shares for reported $93413.0